Long-term cardiovascular risk of white-coat hypertension with normal night-time blood pressure values

被引:6
|
作者
Faria, Joao [1 ]
Mesquita-Bastos, Jose [2 ]
Bertoquini, Susana [3 ]
Silva, Jose [3 ]
Barbosa, Loide [3 ]
Polonia, Jorge [1 ]
机构
[1] Univ Porto, Fac Med, Dept Med & Cintesis, Porto, Portugal
[2] Aveiro Univ, Hlth Sch, Aveiro, Portugal
[3] ULS, Hosp Pedro Hispano, Hypertens Unit, Matosinhos, Portugal
关键词
cardiovascular events; normal night-time blood pressure; white-coat hypertension; MASKED HYPERTENSION; COST-EFFECTIVENESS; PROGNOSTIC VALUE; PRIMARY-CARE; EVENTS; STROKE; PREVALENCE; DISEASES;
D O I
10.1097/MBP.0000000000000364
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background The prognostic impact of white-coat hypertension (WCHT) is still a matter of debate and controversy. Night-time blood pressure (NBP) is related strongly to cardiovascular (CV) prognosis, but this has not been considered currently in the definition of WCHT. Patients and methods We investigated the long-term CV prognosis of 2659 patients submitted at admission to 24 h-ambulatory blood pressure (BP) monitoring divided into three groups: normotension (NT) (n=812; 59% female; ageing 49 +/- 13 years), sustained hypertension (SHT) (n=1230; 56% female; ageing 51 +/- 13 years) and WCHT (n=617; 55% female; ageing 50 +/- 3 years) defined as office BP of at least 140/90 mmHg, daytime BP less than 135/85 mmHg and NBP less than 120/70 mmHg. Results The median follow-up was 7.6 years (range: 0.4-24.4), during which a total of 257 CV events (36 fatal) occurred (46% strokes, 32% coronary and 22% others), 38 in NT, 31 in WCHT and 188 in SHT. The event rate per 100 patient-years was 0.60 in the WCHT group, 0.66 in the NT group and 2.09 in the SHT group. Cox's regression analysis adjusted for covariables showed a higher risk of CV events in patients with SHT than WCHT [hazard ratio (HR)=2.230, 95% confidence interval: 1.339-3.716, P=0.002], whereas there was no difference between WCHT and NT groups. Event-free survival was significantly different from SH versus WCHT and NT groups. Within the group of WCHT, 29% of patients received sustained antihypertensive medication during the follow-up, but the HR of CV events between WCHT either treated or not treated did not differ: HR=0.76 (95% confidence interval: 0.37-1.51, P=0.42). Conclusion In patients with WCHT defined by normal daytime and NBP values, the risk of CV events was significantly lower than that of SHT and similar to that of NT patients, suggesting that NBP should be included in the WCHT definition and in its prognostic stratification.
引用
收藏
页码:59 / 66
页数:8
相关论文
共 50 条
  • [21] The long-term reproducibility of the white-coat effect on blood pressure as a continuous variable from the Ohasama Study
    Satoh, Michihiro
    Yoshida, Tomoya
    Metoki, Hirohito
    Murakami, Takahisa
    Tatsumi, Yukako
    Hirose, Takuo
    Takabatake, Kyosuke
    Tsubota-Utsugi, Megumi
    Hara, Azusa
    Nomura, Kyoko
    Asayama, Kei
    Kikuya, Masahiro
    Hozawa, Atsushi
    Imai, Yutaka
    Ohkubo, Takayoshi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] An Observational Study of the Influence of "White-coat Hypertension" on Day-of-Surgery Blood Pressure Determinations
    Drummond, John C.
    Blake, Jacob L.
    Patel, Piyush M.
    Clopton, Paul
    Schulteis, Gery
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2013, 25 (02) : 154 - 161
  • [23] Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population
    Johansson, Martina A. K.
    ostgren, Carl Johan
    Engvall, Jan
    Swahn, Eva
    Wijkman, Magnus
    Nystrom, Fredrik H.
    JOURNAL OF HYPERTENSION, 2021, 39 (10) : 2009 - 2014
  • [24] White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage
    Mancia, Giuseppe
    Facchetti, Rita
    Vanoli, Jennifer
    Dell'Oro, Raffaella
    Seravalle, Gino
    Grassi, Guido
    HYPERTENSION, 2022, 79 (05) : 1057 - 1066
  • [25] Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database
    Tocci, Giuliano
    Presta, Vivianne
    Figliuzzi, Ilaria
    El Halabieh, Nadia Attalla
    Battistoni, Allegra
    Coluccia, Roberta
    D'Agostino, Michela
    Ferrucci, Andrea
    Volpe, Massimo
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (02) : 297 - 305
  • [26] Setting Thresholds to Varying Blood Pressure Monitoring Intervals Differentially Affects Risk Estimates Associated With White-Coat and Masked Hypertension in the Population
    Asayama, Kei
    Thijs, Lutgarde
    Li, Yan
    Gu, Yu-Mei
    Hara, Azusa
    Liu, Yan-Ping
    Zhang, Zhenyu
    Wei, Fang-Fei
    Lujambio, Ines
    Mena, Luis J.
    Boggia, Jose
    Hansen, Tine W.
    Bjoerklund-Bodegard, Kristina
    Nomura, Kyoko
    Ohkubo, Takayoshi
    Jeppesen, Jorgen
    Torp-Pedersen, Christian
    Dolan, Eamon
    Stolarz-Skrzypek, Katarzyna
    Malyutina, Sofia
    Casiglia, Edoardo
    Nikitin, Yuri
    Lind, Lars
    Luzardo, Leonella
    Kawecka-Jaszcz, Kalina
    Sandoya, Edgardo
    Filipovsky, Jan
    Maestre, Gladys E.
    Wang, Jiguang
    Imai, Yutaka
    Franklin, Stanley S.
    O'Brien, Eoin
    Staessen, Jan A.
    HYPERTENSION, 2014, 64 (05) : 935 - +
  • [27] Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain
    Gijon-Conde, Teresa
    Graciani, Auxiliadora
    Lopez-Garcia, Esther
    Guallar-Castillon, Pilar
    Garcia-Esquinas, Esther
    Rodriguez-Artalejo, Fernando
    Banegas, Jose R.
    HYPERTENSION RESEARCH, 2017, 40 (06) : 613 - 619
  • [28] A working definition of white-coat hypertension must include nocturnal blood pressure
    Omboni, Stefano
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (08) : 1183 - 1186
  • [29] Functional and Structural Heart Conditions Associated With White-Coat Hypertension in Comparison With True Hypertension and Normal Blood Pressure States
    Mirdamadi, Ahmad
    Safdari, Mansoureh
    Gharipour, Mojgan
    Garakyaraghi, Mohammad
    Pourmoghadas, Ali
    IRANIAN HEART JOURNAL, 2018, 19 (02): : 50 - 56
  • [30] Should sleep blood pressure be used as a criterion to define white-coat hypertension?
    Muntner, Paul
    Shimbo, Daichi
    JOURNAL OF HYPERTENSION, 2017, 35 (12) : 2372 - 2373